GF
JNCE

Gabelli Funds’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Gabelli Funds’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-526,281
Closed -$974K – 1200
2023
Q1 		$974K Buy
+526,281
New +$974K 0.01% 803